Hazardous effects of tobacco industry funding

Journal of Epidemiology and Community Health

Volumn 57, Issue 8, 2003, Pages 548-549

  Parascandola, M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO;

EDITORIAL; FINANCIAL MANAGEMENT; LUNG CANCER; MEDICAL RESEARCH; POLICY; PREVENTIVE MEDICINE; PUBLIC HEALTH; SMOKING; TOBACCO INDUSTRY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

BIOMEDICAL RESEARCH; HUMANS; PUBLIC HEALTH; PUBLIC RELATIONS; RESEARCH SUPPORT; SMOKING; TOBACCO INDUSTRY;

EID: 0042769063     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.57.8.548     Document Type: Editorial

References (11)

1. Moses H, Braunwald E, Martin JB, et al. Collaborating with industry - choices for the academic medical center. N Engl J Med 2002;347:1371-5.
2. College of Public Health Tobacco Industry Funding Policy. Available at: http://www.publichealth.arizona.edu/tobacco/policy.htm (accessed 2 Dec 2002).
3. Cancer Research. Preventing lung cancer: isolating the tobacco industry. Consultation Document Reviewing the Cancer Research UK Code of Practice on Tobacco Funding to Universities. London: Cancer Research UK, 2002.
4. Fields N, Chapman S. Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist. J Epidemiol Community Health 2003;57:571-8.
5. Jensen CO. [Letter to Dr. E. L. Wynder, Memoria Hospital]. 7 Jan 1958. Lorillard. Bates Number: 00066298/6299. http://legacy.library.ucsf.edu/tid/qdm51e00 (accessed 2 Dec 2002).
6. Spears AW. [Letter to Dr. E. L. Wynder, Sloan-Kettering Cancer Institute]. 17 Mar 1962. Lorillard. Bates No. 87657326/7327. http://legacy.library.ucsf.edu/tid/mnr21e00 (accessed 2 Dec 2002).
7. Davies DL. [Letter to Dr. Alex W. Spears, Lorillard Research Center]. 30 Aug 1976. Lorillard. Bates Number: 01421024/1025 (accessed 2 Dec 2002).
8. Testimony of Dr Ernest L Wynder. False and misleading advertising (Filter-Tip Cigarettes). Hearings before a Subcommittee of the Committee on Government Operations. Washington, DC: US House of Representatives, 85th Congress, First Session, July 18, 19, 23-26, 1957.
9. Reviewing progress made toward the development and marketing of a less hazardous cigarette. Hearings before the Consumer Subcommittee of the Committee on Commerce. Washington, DC: US House of Representatives, 90th Congress, First Session, August 23-25, 1967.
10. Berridge V. Why have attitudes to industry funding of research changed? Addiction 1997;92:965-8.
11. Filtered for safety. Time 29 Jul 1957.